Origin Agritech completes Second Notes Repurchase Agreement with Citadel Equity Fund

NewsGuard 100/100 Score

Origin Agritech Limited (NASDAQ: SEED) (“Origin” or the “Company”) today announced that it completed its Second Notes Repurchase Agreement (the “Agreement”) as of December 30, 2009 with Citadel Equity Fund Ltd. (“Citadel”) of the remaining portion of the Company’s outstanding 1% Guaranteed Senior Secured Convertible Notes due 2012 (the “Notes”) by full repayment in cash of the agreed upon purchase price due to Citadel.

Liang Yuan, Chief Executive Officer of Origin Agritech, stated, “Origin has never been in a stronger position strategically, technologically, and, most appropriately, financially, in this situation. We are repurchasing our notes based on this strength. Our current cash receipts from this FY 2010 selling season are again the highest in our history, and this should continue to be evident in the first quarters on our balance sheet. We repaid our debt to eliminate any possible dilution and demonstrate our upcoming confidence in the near term future.”

The Company issued the Notes to Citadel in an aggregate principle amount of US$40 million in June 2007, and repurchased $23.4 million in principle of those notes in July 2008 and January 2009. This composes the last tranche of the aggregate principle amount of the remaining US$16.6 million, for a repurchase price of US$104,000 for each principal amount of US$100,000 of such Notes. These repurchased notes have been cancelled.

This Note repurchase provides the Company with the opportunity to eliminate expensive debt on our balance sheet, receive favorable financial terms, and limits company liability going forward in light the current global capital market conditions, which should provide the company with significant flexibility for future growth and capital opportunities.

http://www.originagritech.com/

Posted in:

Tags:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.